x
Filter:
Filters applied
- Editor
- Research ArticleRemove Research Article filter
- Anti-Müllerian hormoneRemove Anti-Müllerian hormone filter
Publication Date
Please choose a date range between 2017 and 2020.
Author
- Alvarez, Manuel1
- Blockeel, Christophe1
- Braeckmans, Kevin1
- Caanen, Mirte1
- Cornelissen, Ria1
- de Roo, Chloë1
- de Sutter, Petra1
- Drakopoulos, Panagiotis1
- Garcia-Velasco, Juan Antonio1
- Griesinger, Georg1
- Lambalk, Cornelius B1
- Lierman, Sylvie1
- Marca, Antonio la1
- Neves, Ana Raquel1
- Peynshaert, Karen1
- Polyzos, Nikolaus P1
- Rodriguez, Ignacio1
- T'Sjoen, Guy1
- Tilleman, Kelly1
- Tournaye, Herman1
- Weyers, Steven1
Editor's Choice
2 Results
- Article
The performance of the Elecsys® anti-Müllerian hormone assay in predicting extremes of ovarian response to corifollitropin alfa
Reproductive BioMedicine OnlineVol. 41Issue 1p29–36Published online: April 30, 2020- Ana Raquel Neves
- Christophe Blockeel
- Georg Griesinger
- Juan Antonio Garcia-Velasco
- Antonio La Marca
- Ignacio Rodriguez
- and others
Cited in Scopus: 5What is the performance of anti-Müllerian hormone (AMH) as measured by the Elecsys® AMH assay in predicting ovarian response in women treated with 150 µg corifollitropin alfa (CFA)? - Article
Ovarian tissue cryopreservation in female-to-male transgender people: insights into ovarian histology and physiology after prolonged androgen treatment
Reproductive BioMedicine OnlineVol. 34Issue 6p557–566Published online: March 21, 2017- Chloë De Roo
- Sylvie Lierman
- Kelly Tilleman
- Karen Peynshaert
- Kevin Braeckmans
- Mirte Caanen
- and others
Cited in Scopus: 86Female-to-male transgender people (trans men), are faced with the risk of losing their reproductive potential owing to gender affirming hormone treatment and genital reconstructive surgery. Transgender people also tend to start sex reassignment treatment at a young age, when reproductive wishes are not yet clearly defined nor fulfilled (De Sutter, 2001). About one-half of trans men, however, express the desire to have children (Wierckx et al., 2012). It is, therefore, recommended by the most recent Standards of Care of the World Professional Association for Transgender Health to clearly discuss fertility and fertility preservation before any treatment (Coleman et al., 2012).